Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources

References

• Austin, P. C. 2011. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research 46 (3):399–424. doi:10.1080/00273171.2011.568786.
   PubMed Web of Science ®Google Scholar
• Chen, W.C., C. Wang, H. Li, N. Lu, R. Tiwari, Y. Xu, and L. Q. Yue. 2020. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data. Journal of Biopharmaceutical Statistics 30 (3):508–520. doi:10.1080/10543406.2020.1730877.
   PubMed Web of Science ®Google Scholar
• Friedman, J. H. 2001. Greedy function approximation: A gradient boosting machine. Annals of Statistics 29 (5):1189–1232. doi:10.1214/aos/1013203451.
   Web of Science ®Google Scholar
• Haig, G. M., E. Bain, W. Robieson, A. A. Othman, J. Baker, and R. A. Lenz. 2014. A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia. Schizophrenia Bulletin 40 (6):1433–1442. doi:10.1093/schbul/sbt240.
   PubMed Web of Science ®Google Scholar
• Lin, J., M. Gamalo-Siebers, and R. Tiwari. 2022. Ensuring exchangeability in data-based priors for aBayesian analysis of clinical trials. Pharmaceutical Statistics 21 (2): 327–344. doi:10.1002/pst.2172.
   PubMed Web of Science ®Google Scholar
• Lin, J., and J. Lin. 2021. Incorporating propensity scores for evidence synthesis under bayesian framework: Review and recommendations for clinical studies. Journal of Biopharmaceutical Statistics 32 (1):1–22. doi:10.1080/10543406.2021.1882481.
   Web of Science ®Google Scholar
• Liu, M., V. Bunn, B. Hupf, J. Lin, and J. Lin. 2021. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data. Statistics in Medicine 40 (22):4794–4808. doi:10.1002/sim.9095.
   PubMed Web of Science ®Google Scholar
• Lunceford, J. K., and M. Davidian. 2004. Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study. Statistics in Medicine 23 (19):2937–2960. doi:10.1002/sim.1903.
   PubMed Web of Science ®Google Scholar
• Lu, N., C. Wang, W.C. Chen, H. Li, C. Song, R. Tiwari, Y. Xu, and L. Q. Yue. 2022. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources. Journal of Biopharmaceutical Statistics 32 (1): 158–169.
   PubMed Web of Science ®Google Scholar
• Myers, J. A., and T. A. Louis. 2012. Comparing treatments via the propensity score: Stratification or modeling? Health Services & Outcomes Research Methodology 12 (1):29–43. doi:10.1007/s10742-012-0080-3.
   PubMedGoogle Scholar
• Neuenschwander, B., G. Capkun-Niggli, M. Branson, and D. J. Spiegelhalter. 2010. Summarizing historical information on controls in clinical trials. Clinical Trials 7 (1):5–18. doi:10.1177/1740774509356002.
   PubMed Web of Science ®Google Scholar
• Neuenschwander, B., and H. Schmidli. 2020. Use of historical data. In Bayesian Methods in Pharmaceutical Research, 111–137. Chapman and Hall/CRC.
   Google Scholar
• Rosenbaum, P. R., and D. B. Rubin. 1983. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1):41–55. doi:10.1093/biomet/70.1.41.
   Web of Science ®Google Scholar
• Rosenbaum, P. R., and D. B. Rubin. 1984. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Association 79 (387):516–524. doi:10.1080/01621459.1984.10478078.
   Web of Science ®Google Scholar
• Schmidli, H., S. Gsteiger, S. Roychoudhury, A. O’hagan, D. Spiegelhalter, and B. Neuenschwander. 2014a. Robust meta-analytic-predictive priors in clinical trials with historical control information. Biometrics 70 (4):1023–1032. doi:10.1111/biom.12242.
   PubMed Web of Science ®Google Scholar
• Schmidli, H., S. Gsteiger, S. Roychoudhury, A. O’hagan, D. Spiegelhalter, and B. Neuenschwander. 2014b. Robust meta-analytic-predictive priors in clinical trials with historical control information. Biometrics 70 (4):1023–1032. doi:10.1111/biom.12242.
   PubMed Web of Science ®Google Scholar
• Schmidli, H., D. A. Häring, M. Thomas, A. Cassidy, S. Weber, and F. Bretz. 2020. Beyond randomized clinical trials: Use of external controls. Clinical Pharmacology & Therapeutics 107 (4):806–816. doi:10.1002/cpt.1723.
   PubMed Web of Science ®Google Scholar
• Thorlund, K., L. Dron, J. J. Park, and E. J. Mills. 2020. Synthetic and external controls in clinical trials–a primer for researchers. Clinical Epidemiology 12:457. doi:10.2147/CLEP.S242097.
   PubMed Web of Science ®Google Scholar
• Wang, C., H. Li, W.C. Chen, N. Lu, R. Tiwari, Y. Xu, and L. Q. Yue. 2019. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies. Journal of Biopharmaceutical Statistics 29 (5):731–748. doi:10.1080/10543406.2019.1657133.
   PubMed Web of Science ®Google Scholar
• Wang, C., N. Lu, W.C. Chen, H. Li, R. Tiwari, Y. Xu, and L. Q. Yue. 2020. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies. Journal of Biopharmaceutical Statistics 30 (3):495–507. doi:10.1080/10543406.2019.1684309.
   PubMed Web of Science ®Google Scholar
• Westreich, D., J. Lessler, and M. Jonsson Funk. 2010. Propensity score estimation: Neural networks, support vector machines, decision trees (CART), and meta-classifiers as alternatives to logistic regression. Journal of Clinical Epidemiology 63 (8):826–833. doi:10.1016/j.jclinepi.2009.11.020.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., R. A. Hubbard, J. Chubak, J. Roy, and N. Mitra. 2021. Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches. Pharmacoepidemiology and Drug Safety 30 (11):1471–1485. doi:10.1002/pds.5338.
   PubMed Web of Science ®Google Scholar